Evidence map›Paper›PMID 19836068›Full record

ArticleCell2009

Induction of intestinal Th17 cells by segmented filamentous bacteria.

Ivaylo I Ivanov, Koji Atarashi, Nicolas Manel, Eoin L Brodie, Tatsuichiro Shima, Ulas Karaoz, Dongguang Wei, Katherine C Goldfarb, Clark A Santee, Susan V Lynch and 7 more

Abstract read
In one paragraph

Article in Cell, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2,674 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,674citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2,674 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Microbiome and well-being: a meta-analysis.NPJ biofilms and microbiomes · 2025
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Oral delivery of recombinantDrug delivery · 2026
    Article
  7. Review
  8. Gut microbes · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

2,614 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Ivaylo I IvanovMolecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY 10016, USA.
Koji Atarashi
Nicolas Manel
Eoin L Brodie
Tatsuichiro Shima
Ulas Karaoz
Dongguang Wei
Katherine C Goldfarb
Clark A Santee
Susan V Lynch
Takeshi Tanoue
Akemi Imaoka
Kikuji Itoh
Kiyoshi Takeda
Yoshinori Umesaki
Kenya Honda
Dan R Littman

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
MURINE MODEL SYSTEM FOR HIV PATHOGENESISR01AI033856 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LITTMAN, DAN · 1993 to 2008
$4.2M
Regulation of Mucosal Th17 Cell Responses by Intestinal BacteriaK99DK085329 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI IVANOV, IVAYLO IVANOV · 2010 to 2010
$90k
Howard Hughes Medical InstituteNIAID NIH HHS AI33856NIAID NIH HHS R01 AI033856NIDDK NIH HHS K99 DK085329NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

The gastrointestinal tract of mammals is inhabited by hundreds of distinct species of commensal microorganisms that exist in a mutualistic relationship with the host. How commensal microbiota influence the host immune system is poorly understood. We show here that colonization of the small intestine of mice with a single commensal microbe, segmented filamentous bacterium (SFB), is sufficient to induce the appearance of CD4(+) T helper cells that produce IL-17 and IL-22 (Th17 cells) in the lamina propria. SFB adhere tightly to the surface of epithelial cells in the terminal ileum of mice with Th17 cells but are absent from mice that have few Th17 cells. Colonization with SFB was correlated with increased expression of genes associated with inflammation and antimicrobial defenses and resulted in enhanced resistance to the intestinal pathogen Citrobacter rodentium. Thus, manipulation of this commensal-regulated pathway may provide new opportunities for enhancing mucosal immunity and treating autoimmune disease.

Indexed as

AnimalsCell DifferentiationCitrobacter rodentiumGram-Positive BacteriaImmunity, MucosalInterleukin-17Interleukin-22InterleukinsIntestinal MucosaMiceMice, Inbred C57BLMucous MembraneSerum Amyloid A ProteinSpecific Pathogen-Free OrganismsSymbiosisT-Lymphocytes, Helper-InducerInterleukin-17Interleukin-22InterleukinsSerum Amyloid A Protein

Identifiers

PMID19836068
PMCPMC2796826

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.